Home › Funds › Fairmount Funds Management LLC › DNTH
Fairmount Funds Management LLC position in DNTH
DIANTHUS THERAPEUTICS INC COM · Health Care
Fairmount Funds Management LLC reported holding 2,537,191 shares of DNTH (DIANTHUS THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$247.3M, representing 16.35% of its reported portfolio and ranking #2 among its reported holdings. Fairmount Funds Management LLC has disclosed DNTH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Fairmount Funds Management LLC's DNTH position evolved
Fairmount Funds Management LLC first disclosed a stake in DNTH in Q3 2023 at 1,928,503 shares (US$26.4M). The position peaked in Q2 2026 at 2,537,191 shares, worth US$247.3M. Across 12 filings, Fairmount Funds Management LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 2,537,191 shares valued at US$247.3M. Notable position changes include a 43% increase in Q1 2024 (shares fell 14% over the following quarter), a 35% trim in Q4 2025 (shares rose 104% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.93M | $26.36M | New |
| Q4 2023 | 1.93M | $20.06M | Hold |
| Q1 2024 | 2.76M | $82.89M | Add |
| Q2 2024 | 2.76M | $71.50M | Hold |
| Q3 2024 | 2.70M | $73.94M | Reduce |
| Q4 2024 | 2.70M | $58.88M | Hold |
| Q1 2025 | 2.70M | $48.99M | Hold |
| Q2 2025 | 2.71M | $50.43M | Hold |
| Q3 2025 | 3.31M | $130.14M | Add |
| Q4 2025 | 2.14M | $88.07M | Reduce |
| Q1 2026 | 2.54M | $212.92M | Add |
| Q2 2026 | 2.54M | $247.33M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DNTH and 13F data
DNTH (DIANTHUS THERAPEUTICS INC COM) is a Health Care company. 72 other funds we track also report a position in DNTH — the largest reported positions include Avidity Partners Management LP (US$205.1M), Octagon Capital Advisors LP (US$179.5M), TCG Crossover Management, LLC (US$163.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DNTH
- Avidity Partners Management LP 2.10M sh · $205.12M · Q2 2026
- Octagon Capital Advisors LP 1.84M sh · $179.53M · Q2 2026
- TCG Crossover Management, LLC 1.68M sh · $163.44M · Q2 2026
- FRED ALGER MANAGEMENT, LLC 1.30M sh · $126.97M · Q2 2026
- Venrock Adviser, LLC 1.18M sh · $115.03M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.13M sh · $109.70M · Q2 2026
- BAKER BROS. ADVISORS LP 852.16K sh · $83.07M · Q2 2026
- Logos Global Management LP 800.00K sh · $77.98M · Q2 2026
- Cormorant Asset Management, LP 750.00K sh · $73.11M · Q2 2026
- BRAIDWELL LP 594.56K sh · $57.96M · Q2 2026
- MPM BioImpact LLC 420.00K sh · $40.94M · Q2 2026
- Affinity Asset Advisors, LLC 400.00K sh · $38.99M · Q2 2026
More on Fairmount Funds Management LLC
FAQ
How long has Fairmount Funds Management LLC held DNTH?
Fairmount Funds Management LLC has disclosed DNTH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Fairmount Funds Management LLC's current position in DNTH?
As of Q2 2026, Fairmount Funds Management LLC holds 2.54M shares of DNTH (DIANTHUS THERAPEUTICS INC COM), valued at $247.33M, representing 16.35% of its reported portfolio and ranking #2.
Has Fairmount Funds Management LLC been buying or selling DNTH?
In the latest 13F filing (Q2 2026), Fairmount Funds Management LLC held unchanged its position in DNTH. The position peaked in Q2 2026 at 2.54M shares.
Which other funds hold DNTH?
Other major institutional holders of DNTH include Avidity Partners Management LP, Octagon Capital Advisors LP, TCG Crossover Management, LLC, among 72 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.